Shots: The P-II clinical study involves assessing ACE-083 in FSHD patient with muscle weakness in the biceps brachii, the tibialis anterior, and a muscle in the lower leg involved in […]readmore
Tags : Facioscapulohumeral Muscular Dystrophy
Shots: GSK to receive shares of Fulcrum’s preferred stock, milestones & royalties on sales of losmapimod. Fulcrum to get exclusive WW rights to develop & commercialize of losmapimod with all […]readmore